Brainstorm Cell Company Top Insiders
BCLI Stock | USD 1.51 0.09 5.63% |
Brainstorm Cell employs about 29 people. The company is managed by 14 executives with a total tenure of roughly 23 years, averaging almost 1.0 years of service per executive, having 2.07 employees per reported executive. Assessment of Brainstorm Cell's management performance can provide insight into the firm performance.
Chaim Lebovits CEO President CoCEO |
Brainstorm Cell's Insider Buying Vs Selling
50
Selling | Buying |
Latest Trades
2024-09-30 | Chaim Lebovits | Acquired 1466 @ 3.45 | View | ||
2024-07-19 | Ibrahim B. Dagher | Disposed 4200 @ 5.25 | View |
Monitoring Brainstorm Cell's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Brainstorm |
Brainstorm Cell Management Team Effectiveness
The company has return on total asset (ROA) of (1.782) % which means that it has lost $1.782 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.219) %, meaning that it created substantial loss on money invested by shareholders. Brainstorm Cell's management efficiency ratios could be used to measure how well Brainstorm Cell manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Brainstorm Cell's Return On Capital Employed is increasing as compared to previous years. The Brainstorm Cell's current Return On Equity is estimated to increase to 3.72, while Return On Tangible Assets are projected to decrease to (4.29). The current Total Assets is estimated to decrease to about 4 M. The current Non Current Assets Total is estimated to decrease to about 1.6 MThe Brainstorm Cell's current Common Stock Shares Outstanding is estimated to increase to about 45.2 M, while Net Loss is forecasted to increase to (20.8 M).
Brainstorm Cell Workforce Comparison
Brainstorm Cell Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,924. Brainstorm Cell claims roughly 29.0 in number of employees contributing just under 2% to equities under Health Care industry.
Brainstorm Cell Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Brainstorm Cell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Brainstorm Cell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Brainstorm Cell insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Arbel Irit over three weeks ago Acquisition by Arbel Irit of 25333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3 | ||
Chaim Lebovits over a month ago Acquisition by Chaim Lebovits of 135000 shares of Brainstorm Cell at 0.3753 subject to Rule 16b-3 | ||
Patlis Alla over two months ago Disposition of 9600 shares by Patlis Alla of Brainstorm Cell at 9.51 subject to Rule 16b-3 | ||
Chaim Lebovits over two months ago Acquisition by Chaim Lebovits of 1836 shares of Brainstorm Cell at 3.4272 subject to Rule 16b-3 | ||
Chaim Lebovits over two months ago Acquisition by Chaim Lebovits of 22000 shares of Brainstorm Cell at 0.228 subject to Rule 16b-3 | ||
Uri Yablonka over two months ago Acquisition by Uri Yablonka of 13333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3 | ||
Dagher Ibrahim B. over three months ago Disposition of 63000 shares by Dagher Ibrahim B. of Brainstorm Cell at 0.3503 subject to Rule 16b-3 | ||
Hartounian Hartoun over three months ago Insider Trading |
Brainstorm Cell Notable Stakeholders
A Brainstorm Cell stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Brainstorm Cell often face trade-offs trying to please all of them. Brainstorm Cell's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Brainstorm Cell's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Chaim Lebovits | President CoCEO | Profile | |
Hartoun Hartounian | Executive COO | Profile | |
Ralph Kern | COO and Chief Medical Officer | Profile | |
Uri Yablonka | COO and Director | Profile | |
Antal PearlLendner | VP Counsel | Profile | |
Daniel Offen | Chief Advisor | Profile | |
Ibrahim MD | Executive Officer | Profile | |
Mary Turner | Senior Affairs | Profile | |
Netta BlondheimShraga | Senior Development | Profile | |
Stacy Lindborg | CoChief Officer | Profile | |
PharmD MBA | Ex COO | Profile | |
Yael Gothelf | Vice Affairs | Profile | |
Irit DSc | CoFounder Board | Profile | |
William White | Senior Pricing | Profile |
About Brainstorm Cell Management Performance
The success or failure of an entity such as Brainstorm Cell Ther often depends on how effective the management is. Brainstorm Cell management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Brainstorm management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Brainstorm management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (4.09) | (4.29) | |
Return On Capital Employed | 5.97 | 6.27 | |
Return On Assets | (4.09) | (4.29) | |
Return On Equity | 3.54 | 3.72 |
Brainstorm Cell Workforce Analysis
Traditionally, organizations such as Brainstorm Cell use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Brainstorm Cell within its industry.Brainstorm Cell Manpower Efficiency
Return on Brainstorm Cell Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 592.8K | |
Net Loss Per Executive | 1.2M |
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |